We determined the tumoricidal effects of the AXL inhibitor gilteritinib on cell growth, apoptotic cell death, cell cycle arrest, migration, and invasion in AXL-positive EC, OC, and GC cells in vitro and ex vivo. Here, AXL is linked to gastric cancer.